|
|
|
市場調查報告書
乳腺疾病診斷及治療市場（2009年）：歐洲及亞太地區
BREAST DISEASE DIAGNOSIS AND THERAPY MARKETS in 2009: EUROPE AND ASIA-PACIFIC
|
乳腺疾病診斷及治療市場（2009年）：歐洲及亞太地區 是由出版商Life Science Intelligence, Inc.在2009年04月所出版的。
這份英文市場調查報告書包含241 Pages / 95 Exhibits 價格從美金6995起跳。
Abstract
The market for breast cancer detection, diagnosis, and treatment is
well-developed in the U.S. and much of Europe. It has remained relatively
under-developed in the Asia-Pacific region, however, although recent trends
suggest that the opportunities for device manufacturers are improving, driven
by the growing prevalence of breast disease in these countries.
In the U.S. and Europe, mammography is the standard of care for the early
detection of breast cancer. Broader adoption is expected in the Asia-Pacific
region, however, which will contribute to higher rates of detection. Outside
of the U.S., the vast majority of ultrasound and magnetic resonance imaging
(MRI) systems are used for general radiology and are not dedicated
specifically to imaging the breast. The ability of these systems to
differentiate between tissue types that cannot be distinguished by mammography
should contribute to incremental sales in Europe and the Asia-Pacific region.
Higher rates of detection resulting from the broader adoption of imaging
systems should contribute to sales of biopsy devices, which are used to
confirm the presence of breast cancer.
This report covers the market for the detection, diagnosis, and treatment of
breast disease in selected countries in Europe and the Asia-Pacific region
through 2014, and provides an in-depth analysis of the economic and clinical
factors driving sales of mammography, ultrasound, MRI and contrast-enhanced
imaging products, and interventional devices.
Table of Contents
1. EXECUTIVE SUMMARY
- 1.1 Clinical Background and Statistics
- 1.2 Factors Affecting the Market for Breast Cancer
- 1.3 Product Markets
- 1.3.1 Mammography
- 1.3.2 Ultrasound
- 1.3.2.1 Challenges to the Adoption of Ultrasound
- 1.3.2.2 MRI & Contrast-Enhanced Imaging
- 1.3.3 Interventional Procedures
- 1.4 Procedure and Market Forecasts
- Exhibit 1-1: Global Rates of Incidence and Survival for Breast Cancer
- Exhibit 1-2: Global Economic Statistics
- Exhibit 1-3: Mammography Procedure Forecast by Region, 2008-2014
- Exhibit 1-4: Ultrasound Procedure Forecast by Region, 2008-2014
- Exhibit 1-5: MRI Procedure Forecast by Region, 2008-2014
- Exhibit 1-6: Biopsy Procedure Forecast by Region, 2008-2014
- Exhibit 1-7: Breast Diag. & Ther. Device Sales in Europe, 2008-2014
- Exhibit 1-8: Breast Diag. & Ther. Device Sales in Asia-Pacific, 2008-2014
2. BREAST DISEASE - BACKGROUND AND STATISTICS
- 2.1 Breast Anatomy
- 2.2 Malignant Breast Disease
- 2.2.1 Invasive Breast Cancer
- 2.2.2 Ductal Carcinoma in situ
- 2.2.3 Atyp. Ductal Hyperplasia/Atyp. Lobular Hyperplasia
- 2.2.4 Tumor Staging
- 2.3 Risk Factors: Breast Cancer
- 2.4 Disease Prevalence and Forecasts
- 2.5 Benign Breast Disease
- 2.5.1 Fibroadenoma
- 2.5.2 Cyst
- 2.5.3 Fibrocystic Disease
- 2.5.4 Benign Papilloma
- 2.6 Summary
- Exhibit 2-1: Breast Anatomy and Malignant Disease States
- Exhibit 2-2: Inconsistency in DCIS/ADH Diagnosis
- Exhibit 2-3: Breast Cancer Staging and Survivability
- Exhibit 2-4: Breast Cancer Staging and Treatment Options
- Exhibit 2-5: Worldwide Distribution of Breast Cancer
- Exhibit 2-6: Breast Cancer Diagnosis & Mortality, Trends & Forecasts
3. REGIONAL FACTORS AFFECTING BREAST CANCER MORTALITY
- 3.1 Regional Factors Affecting Breast Cancer Mortality
- 3.2 Economics, Screening, Incidence, and Lifestyle
- 3.3 Healthcare Payment: Public vs. Private
- 3.4 Distribution
- 3.5 Geopolitical Regions
- 3.5.1 Europe
- 3.5.1.1 France
- 3.5.1.2 Germany
- 3.5.1.3 United Kingdom
- 3.5.1.4 Scandinavian Countries
- 3.5.1.5 Other Countries, Northern/Western Europe
- 3.5.1.6 Countries in Southern/Western Europe
- 3.5.1.7 Countries of the Former Soviet Union
- 3.5.2 Asia-Pacific
- 3.5.2.1 China
- 3.5.2.2 India
- 3.5.2.3 Japan
- 3.5.2.4 Australia/New Zealand
- 3.5.2.5 Rest of Asia
- Exhibit 3-1: Severity of Cancer: Diagnosis, Mortality, and Early Detection
- Exhibit 3-2: European Regions Covered in this Report
- Exhibit 3-3: European Population Forecast, 2008 to 2014
- Exhibit 3-4: Relevant Economic Statistics in Europe
- Exhibit 3-5: Rates of Incidence and Survival for Breast Cancer in Europe
- Exhibit 3-6: Mammography Frequency and Compliance in Europe
- Exhibit 3-7: Hospital Beds per 1,000,000 Population in Europe, 1996-2014
- Exhibit 3-8: Countries Included in the Asia-Pacific Region
- Exhibit 3-9: Insured and Uninsured Populations in China
- Exhibit 3-10: Population Forecasts for Asia-Pacific Countries, 2008-2014
- Exhibit 3-11: Economic Demographics in the Asia-Pacific Region
- Exhibit 3-12: Millionaires in Different Countries and Regions During 2008
- Exhibit 3-13: Breast Cancer Screening in the Asia-Pacific Region in 2008
- Exhibit 3-14: Number of Hospitals in India and the U.S.
4. MAMMOGRAPHY
- 4.1 Devices Costs
- 4.2 Screening and Diagnostic Mammography
- 4.3 Mammography Process
- 4.3.1 Image Acquisition
- 4.3.2 Detection (Screening) vs. Diagnosis
- 4.3.3 Certifications for Radiologists
- 4.3.4 Viewing the Images
- 4.3.5 Diagnostic Exam
- 4.4 Reimbursement
- 4.5 Product Offerings
- 4.5.1 Image Acquisition Systems
- 4.5.1.1 Types of Detector
- 4.5.1.1.1 Direct vs Indirect Capture
- 4.5.1.1.2 Resolution
- 4.5.1.1.3 Radiation Exposure
- 4.5.1.1.4 Cost
- 4.5.2 Market Analysis
- 4.5.2.1 France
- 4.5.2.2 Germany
- 4.5.2.3 United Kingdom
- 4.5.2.4 Scandinavian Countries
- 4.5.2.5 Countries of Southern / Western Europe
- 4.5.2.6 Countries of the Former Soviet Bloc
- 4.5.2.7 China
- 4.5.2.8 India
- 4.5.2.9 Japan
- 4.5.2.10 Australia/New Zealand
- 4.5.2.11 Rest of Asia
- 4.5.3 Product and Service Revenues
- 4.5.3.1 Europe
- 4.5.3.1.1 Suppliers Shares in Europe
- 4.5.3.2 Asia-Pacific
- 4.5.3.2.1 Supplier Shares in Asia-Pacific
- Exhibit 4-1: Mammography
- Exhibit 4-2: Reduction in Tumor Size: Screening Mammography Programs
- Exhibit 4-3: Insurance Reimbursement Programs in 2008
- Exhibit 4-4: Mammography Process
- Exhibit 4-5: Selected Reimbursement Programs in Europe and Asia-Pacific
- Exhibit 4-6: Digital versus Analog Mammography Systems - Image Quality
- Exhibit 4-7: Digital Mammography Systems by Type of Detector
- Exhibit 4-8: Systems, Resolutions, and Radiation Levels in 2008
- Exhibit 4-9: Mammography Procedure Forecast by Region, 2008-2014
- Exhibit 4-10: Installed Base, Mammography Systems, 2008-2014
- Exhibit 4-11: Decrease in Mortality from U.K. Screening Program, 1995-2004
- Exhibit 4-12: Mammography Systems in Europe, Installed Base, 2008-2014
- Exhibit 4-13: Mammography Systems in Europe, Unit Forecast, 2008-2014
- Exhibit 4-14: Analogue Sales Forecast in Europe, 2008-2014
- Exhibit 4-15: CR Device Sales Forecast in Europe, 2008-2014
- Exhibit 4-16: FFD Device Sales Forecast in Europe, 2008-2014
- Exhibit 4-17: Mammography System Sales in Europe, 2008-2014
- Exhibit 4-18: Supplier Shares in Europe, 2008
- Exhibit 4-19: Mammography Systems, Asia-Pacific, Installed Base, 2008-2014
- Exhibit 4-20: Mammography Systems, Asia-Pacific, Unit Forecast, 2008-2014
- Exhibit 4-21: Analogue Sales Forecast in Asia-Pacific, 2008-2014
- Exhibit 4-22: CR Device Sales Forecast in Asia-Pacific, 2008-2014
- Exhibit 4-23: FFD Device Sales in Asia-Pacific, 2008-2014
- Exhibit 4-24: Mammography System Sales in Asia-Pacific, 2008-2014
- Exhibit 4-25: Supplier Shares in Asia-Pacific, 2008
5. ULTRASOUND
- 5.1 International Markets for Breast Ultrasound Products
- 5.2 The Procedure
- 5.2.1 Screening
- 5.2.2 Guided Biopsy
- 5.2.3 Wire Location
- 5.3 Additional Capabilities
- 5.3.1 Elastography
- 5.3.2 CAD
- 5.3.3 Image Fusion
- 5.4 Regional Procedure & Market Forecasts
- 5.4.1 Europe
- 5.4.1.1 France, Germany, the U.K., and Other Countries in
Northern/Western Europe
- 5.4.1.2 Scandinavian Countries
- 5.4.1.3 Southern/Western European Countries
- 5.4.1.4 Countries of the Former Soviet Bloc
- 5.4.1.5 Supplier Shares in Europe
- 5.4.2 Asia-Pacific
- 5.4.2.1 China
- 5.4.2.2 India
- 5.4.2.3 Japan
- 5.4.2.4 South Korea
- 5.4.2.5 Australia / New Zealand
- 5.4.2.6 Rest of Asia
- 5.4.2.7 Supplier Shares in Asia-Pacific
- Exhibit 5-1: Ultrasound Procedures
- Exhibit 5-2: Mammography & Ultrasound, Dense & Fatty-Replaced Breasts
- Exhibit 5-3: Breast Ultrasound Images
- Exhibit 5-4: Ultrasound in the Dense Breast
- Exhibit 5-5: Ultrasound Procedures Performed in Europe during 2008
- Exhibit 5-6: Ultrasound Procedure Forecast for Europe, 2008-2014
- Exhibit 5-7: Installed Base of Breast Ultrasound Systems in Europe,
2008-2014
- Exhibit 5-8: Ultrasound Units Sold in Europe, 2008-2014
- Exhibit 5-9: Breast Ultrasound Systems, European Sales Forecast, 2008-2014
- Exhibit 5-10: Breast Ultrasound Systems, Sales by Region in Europe,
2008-2014
- Exhibit 5-11: Supplier Shares in Europe, 2008
- Exhibit 5-12: Ultrasound Procedures Performed in Asia-Pacific during 2008
- Exhibit 5-13: Ultrasound Procedure Forecast for Asia-Pacific, 2008-2014
- Exhibit 5-14: Installed Base, Breast Ultrasound Systems in Asia-Pacific,
2008-2014
- Exhibit 5-15: Ultrasound Units Sold in Asia-Pacific, 2008-2014
- Exhibit 5-16: Breast Ultrasound Systems, Asia-Pacific Sales Forecast,
2008-2014
- Exhibit 5-17: Breast Ultrasound System Sales in Asia-Pacific, 2008-2014
- Exhibit 5-18: Supplier Shares in Asia-Pacific, 2008
6. CONTRAST-ENHANCED IMAGING PRODUCTS
- 6.1 Magnetic Resonance Imaging
- 6.1.1 Clinical and Economic Challenges
- 6.1.1.1 Clinical Challenges
- 6.1.1.2 Economic Challenges
- 6.1.1.3 Other Factors
- 6.2 Procedure & Market Forecasts for Europe
- 6.3 Procedures & Market Forecasts, Asia-Pacific
- 6.3.1 Supplier Shares in the Asia-Pacific Region
- 6.4 Breast Specific Gamma Imaging (BSGI)
- Exhibit 6-1: MRI Systems per Million Inhabitants in Europe, 2008-2014
- Exhibit 6-2: European Procedure Forecast, 2008-2014
- Exhibit 6-3: MRI Systems, European Unit Forecast, 2008-2014
- Exhibit 6-4: European Sales Forecast, Breast-Enabled MRI Products,
2008-2014
- Exhibit 6-5: Supplier Shares in Europe, 2008
- Exhibit 6-6: MRI Systems per Million Inhabitants, Asia-Pacific Region,
2008-2014
- Exhibit 6-7: Procedure Forecast for the Asia-Pacific Region, 2008-2014
- Exhibit 6-8: MRI Systems, Unit Forecast for the Asia-Pacific Region,
2008-2014
- Exhibit 6-9: Sales Forecast in Asia-Pacific, Breast-Enabled MRI, 2008-2014
- Exhibit 6-10: Sales Forecast in Asia-Pacific (Excl. China and India),
2008-2014
- Exhibit 6-11: Supplier Shares in the Asia-Pacific Region, 2008
7. INTERVENTIONAL PROCEDURES & PRODUCTS
- 7.1 Biopsy
- 7.1.1 Clinical Results
- 7.1.2 Histopathology
- 7.1.3 Cytopathology
- 7.1.4 Biopsy Methods
- 7.1.4.1 Spring-Loaded Core Needle Biopsy
- 7.1.4.2 Vacuum-Assisted Biopsy
- 7.1.4.2.1 Selected Devices
- 7.1.4.3 Fine Needle Aspiration
- 7.1.5 Biopsy Marking Devices
- 7.2 Alternatives to Biopsy: Breast-Specific Antigens
- 7.3 Brachytherapy
- 7.4 Procedure Forecasts and Market Analyses
- 7.4.1 Vacuum-Assisted Biopsy
- 7.4.2 Spring-Loaded Core Needle Biopsy
- 7.4.3 Brachytherapy
- 7.4.4 European Analysis
- 7.4.4.1 France, Germany, the U.K., and Other
- 7.4.4.2 Scandinavian Countries
- 7.4.4.3 Countries in Southern / Western Europe
- 7.4.4.4 Countries of the Former Soviet Bloc
- 7.4.5 Asia-Pacific
- 7.4.6 Product Sales in the European Region
- 7.4.6.1 Vacuum Assisted Biopsy Products
- 7.4.6.1.1 Supplier Shares
- 7.4.6.2 Spring-Loaded Biopsy Devices
- 7.4.7 Product Sales in the Asia-Pacific Region
- 7.4.7.1 Vacuum-Assisted Biopsy Products
- 7.4.7.1.1 Supplier Shares
- 7.4.7.2 Spring-Loaded Biopsy Devices
- Exhibit 7-1: Core Needle Biopsy Devices
- Exhibit 7-2: Relative Volumes of Biopsy Device Specimens
- Exhibit 7-3: Vacuum-Assisted Biopsy Procedure Forecast in Europe, 2008-2014
- Exhibit 7-4: Vacuum-Assisted Biopsy Procedure Forecast, Asia-Pacific,
2008-2014
- Exhibit 7-5: Spring-Loaded Biopsy Procedure Forecast in Europe, 2008-2014
- Exhibit 7-6: Spring-Loaded Biopsy Procedure Forecast, Asia-Pacific,
2008-2014
- Exhibit 7-7: Installed Base, Vac.-Assisted Biopsy Devices in Europe,
2008-2014
- Exhibit 7-8: Vacuum-Assisted Biopsy Device Sales in Europe, 2008-2014
- Exhibit 7-9: Supplier Shares in Europe, 2008
- Exhibit 7-10: Spring-Loaded Biopsy Device Sales in Europe, 2008-2014
- Exhibit 7-11: Installed Vac.-Assisted Biopsy Systems in Asia-Pacific,
2008-2014
- Exhibit 7-12: Vac.-Assisted Biopsy Sales in the Asia-Pacific Region,
2008-2014
- Exhibit 7-13: Supplier Shares in the Asia-Pacific Region, 2008
8. COMPANY PROFILES
- 8.1 Aloka
- 8.2 Aurora Imaging Technology
- 8.3 B-K Medical
- 8.4 Carestream Health
- 8.5 CR Bard
- 8.6 Esaote
- 8.7 FUJIFILM Medical Systems
- 8.8 General Electric
- 8.9 Hitachi
- 8.10 Hologic
- 8.11 i-CAD
- 8.12 Johnson & Johnson (Ethicon Endosurgery and Ethicon)
- 8.13 Mindray
- 8.14 Philips Electric
- 8.15 SenoRx
- 8.16 Siemens
- 8.17 Toshiba
|
 |
